Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling

Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling

Immunotherapy is a promising new therapeutic approach for neuroblastoma (NBM): an anti-GD2 vaccine combined with orally administered soluble beta-glucan is undergoing a phase II clinical trial and nivolumab and ipilimumab are being tested in recurrent and refractory tumors. Unfortunately, predictive...

Celý popis

Podrobná bibliografie
Hlavní autoři: Salvo Danilo Lombardo, Mario Presti, Katia Mangano, Maria Cristina Petralia, Maria Sofia Basile, Massimo Libra, Saverio Candido, Paolo Fagone, Emanuela Mazzon, Ferdinando Nicoletti, Alessia Bramanti
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2019-08-01
Edice:Brain Sciences
Témata:
neuroblastoma
PD-L1
computational modelling
immunotherapy
COPASI
On-line přístup:https://www.mdpi.com/2076-3425/9/9/221

Internet

https://www.mdpi.com/2076-3425/9/9/221

Podobné jednotky